Daily non-political popular news in brief.

Taking a Jab at Cancer

Vaccines that train a person's immune system to kill cancerous cells, when combined with drugs that block tumor defense mechanisms, are starting to show promise.

Read more »

Keywords: taking, jab, cancer

« Previous | Next »

Similar news on "Taking a Jab at Cancer":

1. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
   04-17-2007 · EurekAlert!
   As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
   Similar news · Read more »
   
2. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
   09-06-2007 · EurekAlert!
   More than 10 percent of women with breast cancer stopped taking a commonly prescribed drug because of joint and muscle pain, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
   Similar news · Read more »
   
3. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
   01-21-2008 · EurekAlert!
   Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
   Similar news · Read more »
   
4. Sunshine pill for prostate cancer in 2009
   01-16-2007 · EurekAlert!
   A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
   Similar news · Read more »
   
5. Taking Cancer's Fingerprint: Rapid genetic profiling for personalized therapy
   02-17-2007 · Science News Online
   A new, faster way to identify cancer-causing mutations in the DNA of tumor cells may pave the way for the next generation of custom-tailored cancer therapies.
   Similar news · Read more »
   
6. Heavy multivitamin use may be linked to advanced prostate cancer
   05-15-2007 · EurekAlert!
   While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
7. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
   06-02-2007 · EurekAlert!
   Recent clinical trials revealed that Japanese lung cancer patients survived longer and had a higher rate of side effects than US patients taking the same two drugs, paclitaxel and carboplatin. Now a new study by the Southwest Oncology Group uncovers genetic differences that may explain why. The results, embargoed for release 8:30 a.m. ET Saturday, June 2, are being highlighted at the American Society of Clinical Oncology annual meeting.
   Similar news · Read more »
   
8. Putting risk in perspective: Do people make better decisions when they understand average risk?
   12-13-2007 · EurekAlert!
   If there were a pill that would cut your risk of breast cancer in half, would you take it? What if you were told your risk of breast cancer was already below average? In a newly published survey, women who were told their risk of breast cancer was above average were more likely to endorse taking the hypothetical pill than women who were told their risk was below average.
   Similar news · Read more »
   
9. Custom-made cancer cell attacks
   02-16-2007 · EurekAlert!
   Imagine a cancer treatment tailored to the cells in a patient’s body, each person receiving a unique treatment program. This is what Natural Sciences and Engineering Research Council grantee Thomas Ruth and his colleagues hope to accomplish within the next decade. Using the TRIUMF particle accelerator based in Vancouver, British Columbia, they are taking vast amounts of radioactive material and separating the particular atoms they need for therapy
   Similar news · Read more »
   
10. Tamoxifen yields long-term reduction in breast cancer risk
    02-20-2007 · EurekAlert!
    Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk of the disease, according to two randomized, blinded clinical trials in the February 21 Journal of the National Cancer Institute. The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.
    Similar news · Read more »